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ABSTRACT 
The WHO has declared the COVID-19 epidemic  on January 31, 2020. 
This virus has infected millions of people worldwide in just a few months. 
Shortly afterwards, the National Medical Products Administration (NMPA) 
announced nucleic acid testing as the gold standard for virus detection. 
Antibody testing is used as  well as a supplementary test for suspected cases 
where nucleic acid detection was negative. In short, nucleic acid–based 
polymerase chain reaction (PCR)  is the mainstream detection method for 
clinical samples as well as  for the detection of  SARS-CoV-2 in  wastewaters. 
First data collected around the globe  were reported in the last few months 
being  part of the so-called Wastewater-Based Epidemiology (WBE) approach.  
Selection of  concentration methods  and  primers , laboratory inter-comparison 
and  various modalities of PCR detection of the virus in complex wastewater 
matrices were flagged up as main bullets that require urgent improvement. 
Novel approaches to enhance sensitivity , speed and automate streamlined 
virus detection will be discussed here as well.  This list  comprises devices 
mainly used  for clinical purposes  like Clustered Regularly Interspaced Short 
Palindromic Repeats (CRISPR) , Digital PCR, Lab-on-a-chip  (LOC) and related 
platforms as well as  Biosensors   . The last part will be devoted to  the  
identification of biomolecules to target Covid-19 outbreak  based on  
inflammatory response biomarkers among others. To this end this opinion paper  
brings for  discussion  the issue of PCR detection and its limitations  as well as 
new diagnostic methods  in WBE.  
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Wastewater-based epidemiology (WBE) can be used  as early detection system 
and to determine the scale of  COVID-19 outbreak [1,2]. Determination of 
SARS-CoV-2 is generally carried out with nucleic acid–based polymerase chain 
reaction (PCR) assay, used for confirmation of COVID-19 patients around the 








complicated sample handling in the laboratory, skilled personnel, and a long 
period of data processing and analysis (4-6 h). First data on COVID-19 in 
sewage   using PCR were  reported  for a variety of countries using this method, 
among them   the Netherlands [3], Italy [4, 5], Australia [6] , Spain [7] France [8].  
,Japan [9]  , USA [10, 11],   Ecuador [12] , India [13] and Germany [14]. This 
PCR  methodology   relies  on the fact that an average of   15 to 83% of 
patients infected with SARS-CoV-2 have detectable viral RNA in feces, even in 
the absence of gastrointestinal symptoms or diarrhea [15]. Samples may 
continue to remain positive in the stool, even when respiratory tract samples 
become negative whereas urine is often negative.  
Another key step in the PCR determination are the  concentration methods. 
There is a variety of them  in waste waters. In one the US studies [10]  
ultrafiltration and adsorption-elution and electronegative membrane  was 
reported. It pointed out  that no one of the secondary and  final treated effluents 
samples  with chlorine were tested positive for SARS-CoV-2. The second US 
[11] study from  Massachusetts did use a different concentration methods 
based on  unfiltered sewage precipitated with polyethylene glycol 8000 (PEG). 
Remarkably viral titers observed were significantly higher than expected based 
on clinical cases  being  attributed to asymptomatic patients not measured in 
clinical tests.  In  Italy [5] SARS-CoV-2 RNA was detected in raw, but not in 
treated wastewaters (four and two samples, respectively, sampled in two 
dates). Viral RNA  was not detected in the Milano and Monza wastewater 
treatment plants (WWTPs ), equipped with tertiary treatments, being in 
agreement with the case of the Murcia region (Spain)  using as well  tertiary 
treatments  [7].  Interesting to remark that levels of SARS-CoV-2 detected in 
urban rivers of Quito receiving direct discharges of wastewaters are similar to 
those of Valencia and Paris, with 5000-10000 hospitalized cases. The main 
difference was  that in Quito [12] only 750 Covid-19 clinical cases were 
reported, suggesting a lack of  PCR-based diagnosis.  With this said,   the first 
explanation could be related to the fact   that Ecuador is a low sanitation 
country, with not many facilities to  perform the clinical tests . Another point 
could be attributed to a high level of asymptomatic cases, as reported in one of 
the US cases [11].  Another relevant example of a first study in a large country 
comes from India  [13]. WBE surveillance with   reverse transcription- (RT)-
qPCR    was performed  at the Old Pirana WWTP at Ahmedabad, Gujarat, 
which has 106 million liters per day   and receives effluent from Civil Hospital 
treating COVID-19 patients.  Several genes  of SARS-CoV-2 were  detected  
only in the influent with no genes detected in effluent . Increasing levels of 
SARS-CoV-2 genetic loading in the wastewater   did correspond to an  increase 
in the number of active COVID-19 patients in the city. The number of gene 
copies was comparable to those reported in untreated wastewaters of Australia  
[6] . Lastly, the most recent example  is from  Germany [14].  Nine municipal  
WWTPs from different cities of the Federal State of North Rhine-Westphalia  
were sampled. A set of SARS-CoV-2-specific genes, as well as pan-genotypic 
gene sequences  covering other coronavirus types, were  detected using  (RT)-
qPCR.  
 
To this end it should be pointed out that other ways to measure  COVID-19 
outbreak  were already highlighted  in two opinion papers [1,2] such as rapid 








would be certainly one of the best measurement solutions for the rapid and on-
site detection of COVID-19 in sewage waters and humans as well [2,16] and 
also the use of  other biomarkers of exposure [1]. Recent literature reported the 
use of lab-on-a chip (LOC)  procedure [ 17 ] to analyze SARS-Cov-2 outbreak 
mainly for clinical purposes. 
In short, It is obvious that qPCR is the method of choice in most of the 
laboratories involved in WBE to detect SARS-CoV-2. This opinion  paper wants 
to bring  attention to the reader  first that PCR methods  should be improved  in 
terms of comparability and sensitivity when applied to WBE mainly due to the 
complexity of the wastewater matrix . Most importantly is to encourage the 
scientists involved in   virus detection in WBE  to think outside the PCR box  by 








2. Direct Virus Concentration and Detection Methods- PCR based 
 
Detection of SARS-CoV-2 in sewage has been employed  as a complementary  
method  to clinical test .It is an  early warning indicator of virus spreading 
in communities, covering both symptomatic and asymptomatic cases.  As 
already mentioned,  RT-qPCR analysis is  the most commonly used method of 
to determine the concentration of viral RNA copies in wastewater. To notice that 
not only PCR detection is relevant when analyzing wastewaters,  but 
concentration methods  and the RNA extraction protocol are  key  steps of this  
methodology. Generally  similar protocols for the influent, secondary-treated 
sewage are used and a volume of   100mL of untreated wastewater samples is 
sufficient to detect enteric viruses . Most of  methods developed  were used for 
non enveloped enteric viruses such as norovirus,  and hepatitis A virus among 
others. There is a comprehensive list of methods for concentrating viruses from 
wastewater  like electropositive or electronegative membranes , ultrafiltration,  
polyethylene glycol (PEG) precipitation , ultracentrifugation, skimmed-milk 
flocculation,  monolithic adsorption filtration columns  among others. 
Excellent review papers on concentration methods of viruses from wastewater 
were recently published  [15,18,19-22]  . D. Lu [21] did highlight  that  PEG-
based separation method is the most used  for the COVID-19 in WBE. The 
authors indicated as well that  the electronegative membrane filtration method  
may have problems  with the preferential adsorption of organic matter on the 
charged membrane surface and the potential risk of clogging when handling 
turbid  wastewater samples. 
Standardization  of the analytical protocols  for determining  SAR-CoV-2 in 
wastewaters by different PCR platforms is as well a matter of concern.  To  
investigate a bit more in this direction De La Rosa and co-workers   [ 4 ] did 
analyze the presence of SARS-CoV- 2 using three different nested RT-PCR 
assays and one real-time qPCR assay. Primers were also indicated to be very 
relevant using this methodology.  From all the different methods used.  a novel 








As drawbacks it should be indicated that Important information on the analytical 
approach is often lacking, while there is still no optimization of the whole 
protocol:  sampling, sample storage and concentration, RNA extraction and 
detection/quantification. A recent critical review paper [20] identified  the main 
issues for consideration, i.e., the development of validated methodological 
protocols for the virus quantitative analysis in  WBE. The last review on this 
topic from MVA Corpuz et al [22]  highlights the efforts to improve efficiency of 
virus detection and quantification methods in the complex wastewater and 
sludge matrices. 
. 
Novel approaches based on RNA detection like CRISPR and Digital PCR  were 
used for clinical and aquatic environment applications [21,22,23]. . A powerful 
tool is the CRISPR technology, mainly employed in gene editing . CRISPR  is  
based on RNA detection and it can achieve low level detection  within 30-40  
min . A low-cost and accurate CRISPR-Cas12 based lateral flow assay for 
detection of SARS-CoV-2 was already  reported [23]. The entire time of this 
assay is less than 40  min, in contrast, the RT-qPCR  that needs 4 h. 
In recent years, digital PCR (dPCR) has gained attention as a novel approach 
to detect and quantify nucleic acids [24,25]. The major benefit of dPCR over 
qPCR is the direct absolute quantification of virus genome copy numbers in a 
sample without the necessity of external calibration. dPCR platforms can 
generally be divided into two groups: droplet dPCR (emulsion based) and chip-
based dPCR (microfluidic). Digital PCR (dPCR) is at least 10-fold lower than 
that of RT-qPCR   The major advantage of dPCR over qPCR is that it performs 




3.Lab-on-a-chip (LOC) and Related Platforms 
 
An emerging field of microfluidics also known as the lab-on-a-chip (LOC) 
technologies or micro total analysis system includes a wide range of diagnostic 
devices. LOC technologies advanced from original devices that can conduct a 
single task to integrated systems capable of performing complex jobs. Each 
integrated LOC platform typically contains sets of microfluidic elements,  
dedicated to single operations such as reagent storage, fluid transport and  
mixing,  detection, and possibly collection. Currently, the systems consist of 
complex devices with interconnected fluidic micro-channel networks, valves, 
mixers, pumps, reaction chambers, and detectors. In short , they are able to 
perform many laborious benchtop protocols without human applications in 
clinical diagnostics and low-cost mass production. LOC-based techniques are 
widely used for viral detection in clinical applications like in the cases of  Ebola,   
dengue fever  hepatitis  and Human immunodeficiency virus (HIV) as well other 
cases [26-28]. The LOC concept has been expanded using different types of 
configurations called LionX systems adopting miniaturized fluidic manipulation 
platforms and automated  virus detection.  As an example LOC-related 
platforms are depicted in Figure 1  and include Lab-in-a Tube, Lab-in-a Box and 








PCR systems for Point of Care (POC)  or POC technologies (POCT)  
contributed to  diagnosis during pandemics such as the 2014 Ebola outbreak.  In 
this respect, Bill & Melinda Gates Foundation, developed the GeneXpert Ebola 
Assay based on the GeneXpert system. The GeneXpert Ebola Assay is fully 
automated and only requires the placing of the patient sample into the cartridge 
and inserting the cartridge into a compact desktop-level instrument. It takes ≈2 
h for an entire assay. The COVID-19 global pandemic has greatly  speed up the 
development of POCT systems, as well as the number of companies prepared 
to fund such work. There is long list of companies that have developed systems  
for the diagnosis of   COVID-19 like outbreaks  (i) Eiken Chemical Co. in Japan 
based on  multiple testing  using a microfluidic cartridge with 25 wells,  (ii) 
Roche created a POCT system called Cobas® Liat®, a fast and fully automated 
sample-to-answer system based on a PCR capable of testing samples in 20 
min or less .(iii)  ID NOW, from Abbott Laboratories, is a fully integrated sample-
to-answer  that is currently available with modified primers to diagnose the 
COVID-19 virus, (iv) Filmarray®,   with microfluidic technology  integrates 
nucleic acid extraction, purification and PCR amplification into a single chip and 
results in sequential and accurate detection and it was  previously used for the 
detection of Ebola virus.  At present the COVID-19 test kit has been approved 
by the FDA  (v) . GeneXpert® developed by Cepheid™ integrates sample 
preparation, nucleic acid amplification and detection into a small detection kit. 
(vi)  RTisochip® proposed by CapitalBio™ in China can detect 6 common 
respiratory viruses including COVID-19 in a single chip within 1.5 h. This system 
not only detects SARS-CoV-2, but also effectively identifies patients with 
influenza and COVID-19.   
Compared to the SARS-CoV and MERS-CoV outbreaks, LOC has played a 
crucial role in the COVID-19 outbreak. Countries including the USA, China and 
Japan have approved the use of this technology, which fully demonstrates the 
application value of  LOC. Main advantage is that most of these technologies 
can be used  without professional skills. 
Hopefully at certain moment applications to detect  SARS-CoV-2  and other 
viruses in wastewater will be developed based on these  LOC/POCT systems 
that will  enable simple, fast and sensitive virus detection. Such technology is 





The global risk of viral disease outbreaks emphasizes the need for rapid, 
accurate, and sensitive detection techniques to speed up diagnostics allowing 
early intervention [2, 29-33]. Biosensors are simple and cost-effective smart 
sensing systems for rapid, high-sensitivity detection  with an integrated sample 
preparation and  flexible to detect different targets using the same platform 
(such as CRISPR-powered systems), and   able of simultaneous detection of 
different analytes . 
Main types  of biosensor used for clinical  applications are based on     
electrochemical (EC) , surface enhanced Raman scattering (SERS)-based 








resonance (SPR)-based biosensor , genosensors and immunosensors .  Few 
applications  of  biosensors will be reported in more detail below such as SERS 
and FET –based biosensors  and are depicted in Figure 2 and 3.  
Raman scattering-based lateral flow immunoassay(SERS-based LFIA) strip for 
simultaneous detection of influenza A H1N1 virus and human adenovirus 
(HAdV) by using Fe3O4@Ag nanoparticles  was recently reported [32] ( see 
Figure 2).  It performs the following functions: specific recognition and magnetic 
enrichment of target viruses in the solution and SERS detection of the viruses 
on the strip. Based on this strategy, the magnetic SERS strip can directly be 
used for the analyses of real biological samples without any sample 
pretreatment steps. This proposed strip is easy to operate, rapid, stable, and 
can achieve high throughput. 
EC biosensors have been widely used to detect nucleic acids, proteins, small 
molecular antibodies, and viruses. The work of Seo et al. [31]reported a FET 
biosensor for detecting SARS-CoV-2 in clinical samples (see Fig. 3). This 
sensor was produced by coating the gate of the transistor made up of graphene 
sheets, with an antibody that was specific against the SARS-CoV-2 spike 
protein. Desired performance of the sensor was identified with tests conducted 
with antigen as protein, cultured virus, and nasal swab specimens from COVID-
19 patients. This biosensor was further used for the successful detection of viral 
strains in culture medium. 
One of the questions when working with new  technological devices like 
biosensors is to know the limits of detection (LODs). Since this paper targets  
an environmental audience, the readers may not be familiar with the 
terminology used in biosensors applied to virus detection. One of the most 
commonly used measures to express the LOD is the  Plaque  Forming Units 
(PFU)/mL or microL. PFU is a measure used to describe the number of virus 
particles capable of forming plaques per unit volume. Generally is expressed as  
PFU/mL or PFU/ microL  and indicates how much viruses infect a target cell. In 
the case of SERS (see Fig 2) LODs for Lassa fever, West Nile Fever and 
Influenza   were  230 , 195 and 10  PFU/micro-L respectively.    As regards  to 
FET-biosensor devices ( see Fig 3) LODs  for SARS-CoV-2 are in the range of 
16 PFU/mL  or 16x10-3 PFU/microL.  In short, sensitivity with FET-biosensors is 
much better than with SERS-biosensors. 
 
 
The main question here is, similarly as  in the case of  LOC/POC ,  if  any  of 
these devices can be easily switched to also determine viruses in wastewaters.  
A couple of recent works  [16, 33]  reported the possible application of paper-
based sensor devices to virus detection in WBE approach.  The first one [16]  
reports few examples on the use of  paper-based biosensors  as potential 
biosensor devices  to track  like influenza, HIV viruses among others   in 
wastewaters. The results of the second paper [33] were further cross validated 
with a robust electrophoresis and agarose gel image assay, showing promising 
reliability for wastewater analysis 
As far as I am aware a  paper-based device to detect SARS-CoV-2 in 
wastewaters is not yet available. The problem is that wastewaters represent a 
very complex matrix, even more than human fluids and most probably some 
kind of extensive clean up to remove the matrix interferences will be required 








In short, biosensor should be   a fast “sample-to-answer” analysis method which 
can provide quantitative monitoring of nucleic acids and genetic information 
through the analysis of sewage.  The proposed biosensors should show 
advantages including affordability, rapid analysis time, good sensitivity,  






Biomarkers must be discharged through urine and feces and need to be 
specific to human metabolism. Biomarkers  are of interest because they can be  
rather  specific for given  infectious diseases   and  obviously can be used for 
WBE. CG Daughton  [34]  did  write a lot about  biomarkers of endogenous 
human biochemical processes. Such biomarkers  continuously undergo urinary 
or fecal excretion and represent the sum total contributions for the real-time 
population served by any given sewage system. One of the first examples used 
was coprostanol as possible biomarker of estimating population, which is the 
predominant reduced sterol formed in the human gut .Several other  
endogenous biomarkers of positive health versus disease were also reported by 
Ch Daughton in another paper [35] like isoprostanes, desmosines, bone 
turnover markers (BTM), polyamines and monocyte chemoattractant protein 
(MCP)-1  among others.  
With this said,  WBE could target  endogenous biomarkers that are significantly 
elevated in the diseased state, like in the case of Covid-19 outbreak and  
excreted extensively in urine . A good start to evaluate the use of biomarkers 
would be to make use of the fact that COVID-19 can involve remarkable 
inflammatory damage. A well-known biomarker for  oxidative stress is the 
prostaglandin-like class of substances called isoprostanes [36, 1] . The control 
of Inflammatory response biomarkers for the SARS-CoV-2 infection were 
recommended in clinical studies in  the Zhejiang University School of Medicine 
in China and the list includes:  C-reactive protein, procalcitonin, ferritin, D-dimer, 
interleukins  IL-4, IL-6, IL-10 and interferons-γ (IFN-γ) [37].   Recently our group  
was involved in the proteomic identification   of large molecules  in WWT being 
identified as disease  biomarkers  [38]. Such type of approach maybe useful for 
monitoring changes in the proteomic profile of different populations to better 
understand the scale of new epidemiological threats like COVID-19 . 
Analysis  of biomarkers might have several other major advantages over the 
use of PCR  basically on the   detection side since most of the measurements 
for biomarkers molecules are carried out by mass spectrometry(MS) or ELISA  
in contrast to PCR. It is well-known that MS or ELISA provide better accuracy 
and detection limits  and validation of results as compared to standard PCR. 
Other  possible ways to target SARS-CoV-2 via different biomolecules or 
biomarkers in sewage that have not been yet described and were only indicated 
for clinical purposes.  For the COVID-19 testing, apart from the most frequently 
used viral RNA, novel coronavirus exhibits spike proteins which are 
immunogenic hence, immune system is able to produce immunoglobulins to 
trigger an immune response against the pathogen. Importantly, these 
immunoglobulins are not only valuable to detect COVID-19. Immunoglobulin M 








(between 4 and 10 days), whereas immunoglobulin G (IgG) response is 
produced later (around 2 weeks). 
With that being said,  it maybe possible to explore the possibilities to  look for 
the same type of biomarkers,.i.e inflammatory response biomarkers  already 
used in clinical diagnostics    for the early detection of  COVID-19 outbreak in  
WBE. Environmental proteomics seems to be the right  tool that can do this job 





6. Conclusions and recommendations 
 
PCR platforms like RT-qPCR are still the most widely used methods for SARS-
Cov-2  detection in waste waters. As reported earlier, one of the problems is the   
complexity of the wastewater matrix that needs to be   treated and cleaned up 
by using different concentration  methods . 
There is an urgent need as well   to evaluate RT-qPCR methods used  by 
different laboratories with a clear target  to achieve a verification/standardization 
status [3,19].  Several factors such as  qPCR platforms, PCR inhibitors, nucleic 
acid extraction efficiency and low levels of targets may have contributed to the 
observed discrepancies between laboratories. At  present most of the data 
reported  around the globe as first detection on SARS-CV-2 can only say that 
the virus was detected but in most cases it is impossible to compare the data as 
viral content among the laboratories in different countries . Their protocols are 
different  and  require standardization  such as concentration method, PCR 
assay, and process controls .  In addition, the large uncertainty in the viral load 
in feces makes it difficult to determine a typical value that could be  useful in 
WBE and for comparison with clinical data of the COVID-19 patients, including 
asymptomatic ones.  
With this said,  the expected future of PCR in  WBE  needs to incorporate new 
technological developments from the clinical field such as  digital PCR, CSRPP, 
LOC/POC and  FET or SERS biosensors among others . Such technological 
devices should still be adapted to WBE and need to  be   economical, portable, 
and user-friendly  . Sewage sensors, such as paper-based and smartphones for 
SARS-CoV2 detection at the population level have  as well a clear potential for 
early warning of COVID-19 pandemic. Nowadays it is possible to use  
smartphone-based biosensors targeting antibody/antigen targets  as home 
POC technology. Can  smartphome technology be used  for detecting viruses in 
wastewaters?   This will need certainly further developments to adapt  
technologies used in clinical laboratories like LOC/POC and biosensors  to 
WBE . This has been  a common problem in the field of new  biosensors 
technologies for wastewater measurements. One of the reasons for this is that 
the  environmental market is too small as compared to the clinical one  to be 
able to go to mass production biosensor units  for WWTPs worldwide..  But  not 
only in the detection side technologies need to be  implemented. In short, 
WWTP  plays a  key role to improve virus transmission. Based on  analogies 
with  previous studies on SARS and MERS outbreaks, there are reasons to 
conclude that the viral content may be somewhat  controlled  depending on the  







water authorities will push  together in this direction to develop  biosensors  to 
detect early outbreaks of  COVID-19 or any other new virus that may come in 
the future as well as to improve WWTP technologies. 
To this end  the solution  at present to monitor COVID-19 outbreak in WBE 
could be  a combination of technologies and methodological strategies already 
in place such as  PCR technologies and endogenous biomarkers 
measurements using ELISA and or MS.  Why  not using both approaches for 
WBE? That would help to tackle the problems in a more comprehensive and 
professional way. Certainly  many  discrepancies observed up till now could  be 
solved. Both measurement methods got advantages and disadvantages. For 
biomarkers  the chemical measurements are accurate and sensitive but the 
main question is that  most of biomarkers are not specific of a given disease. 
For instance inflammatory response biomarkers  are obviously related to SARS-
CoV-2 but also to other diseases. But an advantage in case of the present 
pandemic  situation would be that the majority of these biomarkers will be 
related to COVID-19 patients . Lastly, WBE seems to detect more possible 
cases of patients, including asymptomatic ones and also other ones who did 
recover form COVID-19. In this sense WBE can provide additional information 
not only on asymptomatic  cases but also on immunized patients who did 
recover from COVID-19 . Based on these data, epidemiologists  could be able 
to estimate if COVID-19 outbreak would become like a  common flu in the years 
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Figure 2. (a) Synthetic Route for Antibody-Modified Fe3O4@Ag 
Magnetic Tags and (b) Schematic Diagram of the Magnetic SERS 
Strip for Detecting Two Respiratory Viruses-Reproduced with 








Figure 3. Schematic diagram of COVID-19 FET sensor operation procedure. Graphene as sensing material is 
selected and SARS-CoV-2 spike antibody is conjugated onto the graphene sheet via 1-pyrenebutyric acid n 
hydroxysuccinimide ester, which is an interfacing molecule used as a probe linker. Reproduced with 








Figure 1. The LionX Systems for NA-Based Virus Detection 
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